SPY312.18+4.10 1.33%
DIA263.17+5.32 2.06%
IXIC9,682.91+74.54 0.78%

Selecta Biosciences Q1 EPS $(0.210) Beats $(0.280) Estimate

Selecta Biosciences (NASDAQ:SELB) reported quarterly losses of $(0.210) per share which beat the analyst consensus estimate of $(0.280) by 25 percent. This is a 32.26 percent increase over losses of $(0.310) per share

Benzinga · 05/07/2020 11:56

Selecta Biosciences (NASDAQ:SELB) reported quarterly losses of $(0.210) per share which beat the analyst consensus estimate of $(0.280) by 25 percent. This is a 32.26 percent increase over losses of $(0.310) per share from the same period last year.